Literature DB >> 23228303

The importance of early diagnosis and treatment of actinic keratosis.

Darrell S Rigel1, Linda F Stein Gold.   

Abstract

Chronic, long-term sun exposure results in genetic changes in epidermal keratinocytes and the development of various skin lesions ranging from actinic keratosis (AK) to skin cancer. AK lesions may first appear as rough, scaly spots on sun-exposed skin, and, although most individual AK lesions do not become invasive cancers, the majority of invasive squamous cell carcinomas originate from AK. Genetic analysis demonstrates that ultraviolet radiation-induced mutations and changes in gene expression are present in squamous cell carcinoma, AK, and clinically normal-appearing perilesional sun-exposed skin, which supports the progressive nature of keratinocyte transformation. The presence of certain clinical features, such as large size, ulceration, or bleeding, suggests an increased risk of disease progression. The risk is also increased by evidence of extensive solar damage, advanced age, and immunosuppression. Early diagnosis and consideration for treatment are indicated to clear actinically damaged sites and diminish the risk of invasive squamous cell carcinoma.
Copyright © 2012 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23228303     DOI: 10.1016/j.jaad.2012.10.001

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  15 in total

1.  Pharmacokinetics and Safety of Ingenol Disoxate Gel Administered Under Maximum-Use Conditions to Patients With Actinic Keratosis.

Authors:  Edward Lain; Torsten Skov; Anders Hall
Journal:  Clin Drug Investig       Date:  2018-03       Impact factor: 2.859

Review 2.  Cutaneous Complications of Targeted Melanoma Therapy.

Authors:  Emily de Golian; Bernice Y Kwong; Susan M Swetter; Silvina B Pugliese
Journal:  Curr Treat Options Oncol       Date:  2016-11

3.  Skin microtopography as a measure of photoaging and risk of squamous cell carcinoma of the skin in a US population.

Authors:  Lawrence Fitzgerald Kuklinski; Michael Scot Zens; Ann E Perry; Adele C Green; Margaret R Karagas
Journal:  Photodermatol Photoimmunol Photomed       Date:  2017-01-17       Impact factor: 3.135

Review 4.  Pharmacoeconomic Considerations in Treating Actinic Keratosis: An Update.

Authors:  Spencer M Vale; Dane Hill; Steven R Feldman
Journal:  Pharmacoeconomics       Date:  2017-02       Impact factor: 4.981

Review 5.  Diagnostic Accuracy of Dermoscopy of Actinic Keratosis: A Systematic Review.

Authors:  Karla L Valdés-Morales; María Luisa Peralta-Pedrero; Fermín Jurado-Santa Cruz; Martha Alejandra Morales-Sánchez
Journal:  Dermatol Pract Concept       Date:  2020-10-26

Review 6.  Molecular cancer prevention: Current status and future directions.

Authors:  Karen Colbert Maresso; Kenneth Y Tsai; Powel H Brown; Eva Szabo; Scott Lippman; Ernest T Hawk
Journal:  CA Cancer J Clin       Date:  2015-08-18       Impact factor: 508.702

7.  Mucin1 expression in focal epidermal dysplasia of actinic keratosis.

Authors:  Enrique Arciniegas; Luz Marina Carrillo; Héctor Rojas; Richard Ramírez; Oscar Reyes; Ambar Suárez; Fabiana Ortega
Journal:  Ann Transl Med       Date:  2015-10

8.  Defining Field Cancerization of the Skin Using Noninvasive Optical Coherence Tomography Imaging to Detect and Monitor Actinic Keratosis in Ingenol Mebutate 0.015%- Treated Patients.

Authors:  Orit Markowitz; Michelle Schwartz; Eleanor Feldman; Amy Bieber; Amanda Bienenfeld; Naveen Nandanan; Daniel M Siegel
Journal:  J Clin Aesthet Dermatol       Date:  2016-05-01

9.  Sequential treatment of multiple actinic keratoses with solaraze and actikerall.

Authors:  Thomas Dirschka; John T Lear
Journal:  Case Rep Dermatol       Date:  2014-07-02

10.  Primary care review of actinic keratosis and its therapeutic options: a global perspective.

Authors:  Praven Chetty; Felix Choi; Timothy Mitchell
Journal:  Dermatol Ther (Heidelb)       Date:  2015-02-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.